Concepedia

Timothy Madden

TM

67

Publications

5.9K

Citations

41

H-Index

1992

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

Cornell University

Timothy Madden is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and oncology.

ORCID

Top concepts

Publications per year

1992–2024

67

Publications

67

Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer

Christos N. Papandreou, Danai Daliani, Darrell Nix et al. · Journal of Clinical Oncology · 2004 · 436 citations · Full text

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

Marcos de Lima, Daniel R. Couriel, Peter F. Thall et al. · Blood · 2004 · 421 citations

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo

Arifumi Iwamaru, Sławomir Szymański, Eiji Iwado et al. · Oncogene · 2006 · 368 citations

, , +11

A Novel Small Molecule Inhibitor of Signal Transducers and Activators of Transcription 3 Reverses Immune Tolerance in Malignant Glioma Patients

S. Farzana Hussain, Ling-Yuan Kong, Justin Jordan et al. · Cancer Research · 2007 · 310 citations

, , +20

Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

Roy S. Herbst, Kenneth R. Hess, Hai T. Tran et al. · Journal of Clinical Oncology · 2002 · 277 citations

Rows per page

1–5 of 67